<table border="1" id="id_4403ac86-6355-4ee5-a121-5021f22cb1d4" width="423.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 1: Ranitidine Pharmacokinetics in Pediatric Patients Following Oral Dosing</caption>
<col span="1" width="19.9%"></col>
<col span="1" width="18.9%"></col>
<col span="1" width="16.5%"></col>
<col span="1" width="19.6%"></col>
<col span="1" width="25.1%"></col>
<tbody>
<tr>
<td>Population (age)</td>
<td>n</td>
<td>Dosage Form (dose)</td>
<td>C<sub>max</sub> (ng/mL)</td>
<td>T<sub>max</sub> (hours)</td>
</tr>
<tr>
<td>Gastric or duodenal ulcer (3.5 to 16 years)</td>
<td>12</td>
<td>Tablets (1 to 2 mg/kg)</td>
<td>54 to 492</td>
<td>2</td>
</tr>
<tr>
<td>Otherwise healthy requiring ranitidine (0.7 to 14 years, Single dose)</td>
<td>10</td>
<td>Syrup (2 mg/kg)</td>
<td>244</td>
<td>1.61</td>
</tr>
<tr>
<td>Otherwise healthy requiring ranitidine (0.7 to 14 years, Multiple dose)</td>
<td>10</td>
<td>Syrup (2 mg/kg)</td>
<td>320</td>
<td>1.66</td>
</tr>
</tbody>
</table>